Cymbalta is the brand name for duloxetine, a prescription medication classified as a serotonin and norepinephrine reuptake inhibitor (SNRI). It works by increasing levels of two chemical messengers in the brain, serotonin and norepinephrine, that play key roles in mood regulation and pain signaling. The FDA has approved it to treat five conditions: major depression in adults, generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain.
How Cymbalta Works in the Brain and Body
Your brain naturally recycles serotonin and norepinephrine after nerve cells release them. Cymbalta blocks that recycling process, leaving more of both chemicals available to keep transmitting signals between nerve cells. This dual action is what distinguishes SNRIs from older antidepressants like SSRIs, which target only serotonin.
Cymbalta also raises dopamine levels in the prefrontal cortex, the part of the brain involved in decision-making and emotional regulation. It does this indirectly: the transporters that normally clear norepinephrine in that region also happen to pick up dopamine. When Cymbalta blocks those transporters, dopamine sticks around longer too.
For pain conditions, the mechanism is different. Cymbalta strengthens a natural pain-dampening pathway that runs from the brain down through the spinal cord. Normally, this pathway sends signals that quiet pain messages before they reach the brain. By boosting serotonin and norepinephrine activity along this route, Cymbalta helps suppress excessive pain signals at the spinal level. This is why a single medication can treat both mood disorders and chronic pain.
Conditions It Treats
Cymbalta is FDA-approved for five uses:
- Major depressive disorder in adults
- Generalized anxiety disorder in adults and children aged 7 and older
- Diabetic peripheral neuropathy (nerve pain from diabetes) in adults
- Fibromyalgia in adults and adolescents aged 13 and older
- Chronic musculoskeletal pain (such as lower back pain or osteoarthritis pain) in adults
Doctors sometimes prescribe it off-label for other types of nerve pain or stress urinary incontinence, but these uses aren’t part of its formal FDA approval in the United States.
Typical Doses
For depression, the usual dose ranges from 40 to 60 mg per day. Some people start at 30 mg for the first week to ease into the medication before moving to 60 mg. Although doses up to 120 mg per day have been studied, research shows no clear benefit beyond 60 mg for most people.
For anxiety and chronic musculoskeletal pain, the target dose is also 60 mg once daily, often with a one-week ramp-up at 30 mg. The same ceiling applies: higher doses tend to produce more side effects without meaningfully better results.
Cymbalta comes as a delayed-release capsule, meaning it’s designed to dissolve in the intestine rather than the stomach. It should be swallowed whole, not crushed or opened.
How Long It Takes to Work
Most people begin noticing improvement within 2 to 4 weeks. If you’re taking Cymbalta for nerve pain, it may take longer. Early changes are often subtle: better sleep, more stable energy, or less irritability before a noticeable lift in mood. It’s common to feel side effects before the therapeutic benefits fully kick in, which can be discouraging but is a normal part of the adjustment period.
Common Side Effects
The most frequently reported side effects include nausea, dry mouth, drowsiness, fatigue, constipation, decreased appetite, and increased sweating. Nausea is often the most bothersome in the first week or two and typically fades as your body adjusts. Starting at a lower dose for the first week helps reduce this.
Some people experience dizziness, blurred vision, or difficulty sleeping. Sexual side effects, including reduced desire and difficulty reaching orgasm, are also relatively common with SNRIs and may not improve over time.
Weight Changes
In the short term, Cymbalta tends to cause slight weight loss due to reduced appetite. After several months, this pattern often reverses. In a year-long study, patients taking 40 to 60 mg twice daily gained an average of about 2.4 pounds. At higher doses (120 mg per day), roughly 13% of patients gained more than 7% of their starting body weight, compared to about 6% on placebo. The effect appears dose-related, meaning higher doses carry a greater likelihood of weight gain.
Serious Risks
Like all antidepressants, Cymbalta carries an FDA boxed warning about an increased risk of suicidal thoughts and behavior in children, teenagers, and young adults under 25 during the first few months of treatment or after dose changes. This risk does not mean the medication causes suicidal behavior in most people, but it does mean close monitoring matters during early treatment.
Cymbalta can raise blood pressure, so periodic checks are important while taking it. It may also affect liver function, particularly in people who drink alcohol heavily or have pre-existing liver disease. Rarely, it can cause a serious condition called serotonin syndrome, especially when combined with other medications that increase serotonin, such as other antidepressants, certain migraine medications (triptans), or the pain reliever tramadol. Symptoms of serotonin syndrome include agitation, rapid heartbeat, high body temperature, and muscle rigidity.
Cymbalta should never be taken with or within 14 days of using an MAO inhibitor, an older class of antidepressant. The combination can trigger a dangerous spike in serotonin levels.
Stopping Cymbalta Safely
Cymbalta is well known for causing withdrawal symptoms if stopped abruptly. This is sometimes called discontinuation syndrome, and it can begin within days of missing doses or stopping cold turkey. Symptoms include nausea, headache, dizziness, irritability, insomnia, excessive sweating, and diarrhea. Some people also report “brain zaps,” brief electric shock-like sensations in the head that are disorienting but not dangerous.
Less commonly, withdrawal can involve rapid mood swings, confusion, agitation, or ringing in the ears. In rare cases, seizures have been reported. Because of these risks, the standard approach is a gradual taper, slowly reducing the dose over weeks or even months under medical supervision. The slower the taper, the milder the withdrawal tends to be. Even with a careful taper, some people experience lingering symptoms for several weeks after their last dose.
If you’ve been on Cymbalta for more than a few weeks, stopping on your own without a tapering plan is not recommended. The withdrawal can be intense enough that some people mistake it for a return of their original condition.